Reading School of Pharmacy, University of Reading, Whiteknights, Reading RG6 6AD, UK.
Bioorg Med Chem. 2011 Sep 15;19(18):5679-92. doi: 10.1016/j.bmc.2011.07.019. Epub 2011 Jul 22.
In this work libraries of morpholines and oxazepanes have been prepared via the reductive amination reaction between dialdehydes, derived from carbohydrates, and a range of amines. In this way, functionalised morpholines and oxazepanes have been prepared that include N-alkylated derivatives, disaccharide analogues, and ester containing derivatives. The abilities of these functionalised morpholines and oxazepanes to inhibit a broad panel of glycosidase enzymes, that are associated with a range of diseases, have been probed and in this way new inhibitors of a range of glycosidases, but particularly β-d-galactosidase derived from Bovine kidney, have been discovered. N-Alkyl morpholines demonstrated the best inhibition profiles for this enzyme and derivatives (15a)-(15d) acted as non-competitive inhibitors with IC(50) values of 55.1-88.6 μM. Within this study, some preliminary structure-activity relationships are proposed, and it is demonstrated that N-substituted morpholines display better inhibitory profiles for the enzymes analysed than any of the N-substituted oxazepanes.
在这项工作中,通过糖醛与一系列胺之间的还原胺化反应,制备了吗啉和噁唑烷的文库。通过这种方式,制备了包括 N-烷基化衍生物、二糖类似物和含有酯的衍生物在内的功能化吗啉和噁唑烷。研究了这些功能化吗啉和噁唑烷抑制一系列糖苷酶的能力,这些糖苷酶与一系列疾病有关,从而发现了一系列糖苷酶的新抑制剂,特别是来源于牛肾的β-D-半乳糖苷酶。N-烷基吗啉对这种酶表现出最好的抑制特性,衍生物(15a)-(15d) 作为非竞争性抑制剂,IC50 值为 55.1-88.6 μM。在这项研究中,提出了一些初步的构效关系,并证明与任何 N-取代的噁唑烷相比,N-取代的吗啉对所分析的酶表现出更好的抑制特性。